HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thymosin a1 use is not associated with reduced COVID-19 mortality.

AuthorsTao Liu, Shengdong Liu, Tao Li, Jingjing Zhang
JournalThe American journal of emergency medicine (Am J Emerg Med) Vol. 53 Pg. 252-253 (03 2022) ISSN: 1532-8171 [Electronic] United States
PMID33896653 (Publication Type: Letter, Review)
Chemical References
  • Thymalfasin
Topics
  • COVID-19 (epidemiology, mortality)
  • Humans
  • Thymalfasin (adverse effects, metabolism, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: